The KEGG pathway enrichment analysis revealed several significantly enriched pathways, with particular emphasis on the Hepatitis B, GnRH signaling pathway, EGFR inhibitor resistance, endocrine resistance, and prostate cancer. The gene discussed is GNRH1; the disease is prostate cancer.